| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Janney Daniel is a Director, 10% Owner at STRO with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 23 sells.
Estimated insider holdings value: $83.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | KRYS Krystal Biotech, Inc. | Director | Sell | 11,803 | $275.59 | $3,252,824.35 | -7.3% | +12.6% | - | |
| Jun 9, 2023 | KRYS Krystal Biotech, Inc. | Director | Sell | 50,000 | $128.36 | $6,418,076.77 | -4.0% | -6.0% | +27.5% | |
| May 19, 2023 | KRYS Krystal Biotech, Inc. | Director | Sell | 50,000 | $95.02 | $4,751,185.00 | -24.1% | +22.6% | +70.8% | |
| May 9, 2023 | KRYS Krystal Biotech, Inc. | Director | Sell | 17,100 | $90.74 | $1,551,578.76 | -7.6% | +18.2% | +71.7% | |
| Apr 19, 2023 | KRYS Krystal Biotech, Inc. | Director | Sell | 7,900 | $90.32 | $713,493.24 | -3.4% | +44.6% | +84.0% | |
| Dec 10, 2021 | KRYS Krystal Biotech, Inc. | Director | Sell | 100,000 | $70.50 | $7,050,000.00 | -27.3% | -7.7% | -0.7% | |
| Aug 30, 2019 | KRYS Krystal Biotech, Inc. | Director | Sell | 88,684 | $46.46 | $4,120,342.54 | -7.1% | - | - | |
| Sep 22, 2017 | KRYS Krystal Biotech, Inc. | Director | Buy | 200,000 | $10.00 | $2,000,000.00 | +153.2% | - | - | |
| Mar 21, 2017 | ESPR Esperion Therapeutics, Inc. | Director | Sell | 350,000 | $45.80 | $16,029,262.91 | -4.6% | - | - |